Efficacy and safety of the dual SGLT1 and 2 inhibitor sotagliflozin in combination with a mineralocorticoid receptor antagonist in patients hospitalized for worsening heart failure

被引：0
|
作者：
Pitt, B. [1 ]
Bhatt, D. L. [2 ]
Szarek, M. [3 ]
Davies, M. [4 ]
Banks, P. [4 ]
Steg, P. G. [5 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Univ Colorado, Sch Med, Aurora, CO USA
[4] Lexicon Pharmaceut Inc, The Woodlands, TX USA
[5] Univ Paris Diderot, Bichat Hosp, INSERM, FACT French Alliance Cardiovasc T,UMR1148, Paris, France
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：192 / 193
页数：2
相关论文
共 50 条
  • [21] EFFECTS OF SGLT 1-2 INHIBITOR SOTAGLIFLOZIN ON SYMPTOMS, PHYSICAL LIMITATIONS AND QUALITY OF LIFE IN PATIENTS WITH WORSENING HEART FAILURE: RESULTS FROM THE SOLOIST TRIAL
    Kosiborod, Mikhail
    Bhatt, Deepak L.
    Szarek, Michael
    Steg, Philippe Gabriel
    Pitt, Bertram
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 279 - 279
  • [22] Sotagliflozin, a Dual SGLT1/2 Inhibitor, Improves Cardiac Outcomes in a Normoglycemic Mouse Model of Cardiac Pressure Overload
    Young, Sophia L.
    Ryan, Lydia
    Mullins, Thomas P.
    Flint, Melanie
    Steane, Sarah E.
    Walton, Sarah L.
    Bielefeldt-Ohmann, Helle
    Carter, David A.
    Reichelt, Melissa E.
    Gallo, Linda A.
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [23] LEVELS OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AND HEART FAILURE OUTCOMES IN PATIENTS WITH TYPE-2 DIABETES AND WORSENING HEART FAILURE TREATED WITH SOTAGLIFLOZIN, A DUAL INHIBITOR OF SODIUM GLUCOSE COTRANSPORTERS 1 AND 2
    Erne, Grace
    Blakely, Pennelope K.
    Anderson, Elizabeth
    Nelapudi, Namratha
    Tripathi, Medha
    Ismail, Anis
    Tekumulla, Annika
    Amadi, Kingsley
    Catalan, Tonimarie
    Vasbinder, Alexi
    Bitterman, Brayden
    Chen, Jiazi
    Tilley, Caroline
    Sulaiman, Noor
    Presswalla, Feriel
    Pizzo, Ian
    Meyette, Nathan
    Steg, Philippe Gabriel
    Szarek, Michael
    Sun, Franklin
    Davies, Michael
    Bhatt, Deepak L.
    Pitt, Bertram
    Hayek, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 664 - 664
  • [24] Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
    Musso, Giovanni
    Gambino, Roberto
    Cassader, Maurizio
    Paschetta, Elena
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [25] Comparison of the Anti-Platelet and Anti-Thrombotic Effects of the Dual SGLT1/2 Inhibitor Sotagliflozin to the Relatively Selective SGLT2 Inhibitor Empagliflozin
    Stanger, Livia
    Yalavarthi, Pooja
    Flores, Mariane
    Creen, David
    Pitt, Bertram
    Holinstat, Michael
    BLOOD, 2024, 144 : 3933 - 3934
  • [26] Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes
    Stougaard, E. B.
    Rossing, P.
    Vistisen, D.
    Banks, P.
    Girard, M.
    Davies, M. J.
    Persson, F.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S47 - S47
  • [27] Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes
    Stougaard, Elisabeth B.
    Rossing, Peter
    Vistisen, Dorte
    Banks, Phillip
    Girard, Manon
    Davies, Michael J.
    Persson, Frederik
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 674 - 675
  • [28] Direct Actions of the Dual SGLT1/2 Inhibitor Sotagliflozin on Functional Recovery following Global Ischemia in Diabetic and Healthy Mouse Hearts
    Dorey, Emily S.
    Cotter, Brooke
    Mullins, Thomas P.
    Reichelt, Melissa E.
    Gallo, Linda A.
    DIABETES, 2020, 69
  • [29] Efficacy and Safety of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Chronic Kidney Disease
    Khan, Mohammad Saud
    Khan, Muhammad Shahzeb
    Moustafa, Abdelmoniem
    Anderson, Allen S.
    Mehta, Rupal
    Khan, Sadiya S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (04): : 643 - 650
  • [30] Combination Therapy Using Sodium Zirconium Cyclosilicate and a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure and Hyperkalemia
    Imamura, Teruhiko
    Oshima, Akira
    Narang, Nikhil
    Ushijima, Ryuichi
    Ueno, Yohei
    Ueno, Hiroshi
    Kinugawa, Koichiro
    INTERNAL MEDICINE, 2021, 60 (13) : 2093 - 2095
12345